Reading time: 3 minutes
Changes in sexual desire during menopause can have a meaningful impact on intimacy and quality of life. PT-141 (bremelanotide) is a peptide that may be an option for some women seeking to improve their sexual health.
How PT-141 May Help Women With Low Libido
PT-141 activates melanocortin receptors in the brain, which are involved in regulating sexual desire and sexual response. Rather than increasing hormone levels, it works through the central nervous system and may help improve several aspects of female sexual function.
It is typically administered as sublingual, intrasnasal or subcutaneous injection 45 minutes before anticipated sexual activity.
Treatment may help support:
- Increased sexual desire
- Improved arousal
- Greater sexual satisfaction
- A non-hormonal treatment option for women who may not be candidates for hormone therapy or prefer an alternative approach
Not every woman responds to PT-141 in the same way, and improvements may become more noticeable after several uses rather than after the first injection.
Who May Be a Candidate for PT-141?
PT-141 may be prescribed for women with acquired, generalized Hypoactive Sexual Desire Disorder (HSDD) and may also be considered for appropriate menopausal women experiencing persistent low sexual desire following an individualized medical evaluation.
Before PT-141 is recommended, a comprehensive evaluation is performed to determine whether medical, hormonal, or lifestyle factors may be contributing to your symptoms.
A comprehensive evaluation may include reviewing:
- Hormone levels
- Current medications
- Medical history
- Menopause symptoms
- Emotional well-being
- Relationship concerns
This evaluation helps determine whether PT-141 is appropriate or whether other therapies may better address the underlying cause of decreased libido.
What to Expect From PT-141 Treatment
If PT-141 is recommended, you will receive instructions on how and when to administer the medication, review potential side effects, and discuss what results are realistic based on your individual needs.
When PT-141 is effective, women may experience increased sexual desire, improved responsiveness during intimacy, and greater sexual satisfaction.
Your response to treatment will be monitored over time to determine whether PT-141 should remain part of your treatment plan or whether other therapies may better address your symptoms.
Women’s Sexual Health Care at Pure Body Health
At Pure Body Health, Dr. Scott Maymon, ND, MPH, and Dr. Sarah Stone, ND, take a comprehensive approach to sexual wellness, evaluating hormonal, medical, and lifestyle factors that may be contributing to low libido.
Depending on your needs, your personalized treatment plan may include hormone optimization, lifestyle recommendations, or non-hormonal therapies such as PT-141. We work to identify the factors affecting your sexual health and recommend treatment options that align with your individual concerns and goals.
Personalized Women’s Health Care in Tempe, AZ
To book an appointment at our wellness clinic in Tempe, AZ, call (480) 427-0442 or visit us at 1553 W Todd Dr #106, Tempe, AZ 85283.
FAQs
Unlike hormone replacement therapy, PT-141 works by activating melanocortin receptors involved in sexual response rather than increasing estrogen or testosterone levels. This makes it a non-hormonal treatment option for appropriate candidates.
PT-141 may cause temporary increases in blood pressure in some individuals. Your healthcare provider will review your medical history and determine whether the medication is appropriate for you before treatment begins.
Although PT-141 is FDA-approved for premenopausal women with acquired, generalized HSDD, it may be prescribed off-label for appropriate postmenopausal women following an individualized medical evaluation.
Unlike some medications used to treat sexual dysfunction, PT-141 primarily works by activating receptors in the brain involved in sexual desire and response rather than by increasing blood flow.